Mergers & Acquisitions - Respiratory and Pulmonary, Mergers & Acquisitions


Popular Filters

1 to 25 of 28 results

Stallergenes expands in Latin American with acquisition of Alergo Pharma

Stallergenes expands in Latin American with acquisition of Alergo Pharma


French allergen specialist Stallergenes said this morning that it has acquired full ownership of Alergo…

Alergo PharmaAllergologyArgentinaImmunologyMedicineMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryStallergenes

AstraZeneca stresses confidence in independence, highlighting strong R&D pipeline


Anglo-Swedish pharma major AstraZeneca, the subject of the controversial takeover attempt by Pfizer,…

AstraZenecaCardio-vascularMergers & AcquisitionsMetabolicsOncologyPharmaceuticalResearchRespiratory and Pulmonary

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators


Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

OPKO to buy Israel’s Inspiro, gaining rights to new drug delivery technology


US biopharma company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical an…

Inspiro MedicalMergers & AcquisitionsOPKO HealthPharmaceuticalRespiratory and Pulmonary

Vectura to buy Germany’s Activaero for 130 million euros

Vectura to buy Germany’s Activaero for 130 million euros


UK developer of inhaled therapies Vectura says it is acquiring privately-held German company Activaero…

ActivaeroFinancialMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

Mast Therapeutics to acquire Aires Pharma


USA-based Mast Therapeutics has entered into a definitive agreement to acquire privately-held clinical-stage…

AIR001Aires PharmaceuticalsMast TherapeuticsMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Ikaria sells commercial business to Madison Dearborn for $1.6 billion


US critical care company Ikaria says that its investor group and employee shareholders have reached a…

IkariaInomaxMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Abraaj sells stake in Opalia Pharma to Recordati


The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

Meda acquires US respiratory company


Swedish drugmaker Meda (STO:MEDAA) has signed an agreement to acquire the US development company Acton…

Acton PharmaceuticalsAerospan HFAFlunisolideMedaMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx


Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire…

Mergers & AcquisitionsMicroDose TherapeutxPharmaceuticalRespiratory and PulmonaryTeva Pharmaceutical Industries

Zambon to acquire UK respiratory specialist Profile Pharma


Family-owned Italian drugmaker Zambon has taken a significant step to grow in the respiratory therapy…

Mergers & AcquisitionsPharmaceuticalProfile PharmaPromixinRare diseasesRespiratory and PulmonaryZambon

AstraZeneca to pay up to $1.15 billion to acquire Pearl Therapeutics


In a further "strategic" bolt-on acquisition for Anglo-Swedish drug major AstraZeneca (LSE: AZN) in less…

AstraZenecaMergers & AcquisitionsPearl TherapeuticsPharmaceuticalPT003Respiratory and Pulmonary

Grifols gains global rights to Aradigm's Pulmaquin


Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

Vectura sets up JV, Kinnovata, for new respiratory business in China


UK-based developer of inhaled therapies Vectura (LSE: VEC) saw its shares rise 4.8% to 96.93 pence in…

Asia-PacificMergers & AcquisitionsPharmaceuticalProductionRespiratory and PulmonaryTianjin KingYorkTianjin Kinnovata PharmaVecturaZendex Bio Strategy

Theravance to split into two, halting speculation of a full takeover by GSK


US drug developer Theravance (Nasdaq: THRX) has announced its intention to create two independent publicly…

Anoro ElliptaBiotechnologyBreo ElliptaGlaxoSmithKlineManagementMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoyalty Management CoTheravanceTheravance Biopharma

Ares Life Sciences to make second 2013 acquisition, the USA's Antigen Laboratories


Ares Life Sciences has signed a definitive agreement to acquire 100% of the share capital of privately-held…

Antigen LaboratoriesAres Life SciencesMergers & AcquisitionsPharmaceuticalPlanet BiopharmaceuticalsRespiratory and Pulmonary

Briefs: Bidding war for Obagi escalates, as Valeant ups offer; AstraZeneca plans to sue Actavis


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) today (April 3) announced…

ActavisAstraZenecaDermatologicalsGenericsLegalMergers & AcquisitionsMerz PharmaceuticalsObagi Medical ProductsPharmaceuticalPulmicort RespulesRespiratory and PulmonaryValeant Pharmaceuticals

Ares Life Sciences to acquire Albion Medical and its GREER Laboratories unit


Ares Life Sciences says it has signed a definitive agreement to acquire 100% of the share capital of…

Albion MedicalAres Life SciencesGREER LaboratoriesImmunologicalsMergers & AcquisitionsOralairPharmaceuticalRespiratory and PulmonaryStallergenes

Briefs: Sanofi to up stake in Regeneron; Bayer files for riociguat approval


US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) saw its shares rise 4.8% to $173.84 in early trading…

BayerBiotechnologyEuropeFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegeneronRegulationRespiratory and PulmonaryriociguatSanofi

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis


French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

Fresenius Kabi sells respiratory homecare business in France


Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Sunovion to acquire Elevation Pharma for up to $430 million


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506) last week…

Dainippon Sumitomo PharmaElevation PharmaceuticalsEP-101Mergers & AcquisitionsPharmaceuticalRespiratory and PulmonarySunovion

GSK and Theravance file for FF/VI approval in the USA and Europe; Talks with Human Genome?


UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Theravance (Nasdaq: THRX) announced on Friday…

BiotechnologyBreoEuropeGlaxoSmithKlineHuman Genome SciencesMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationRelovairRelvarRespiratory and PulmonaryTheravance

InterMune to divest Actimmune for $55 million; to focus on Esbriet


California, USA-based biotech firm InterMune (Nasdaq: ITMN) says that it has reached a definitive agreement…

ActimmuneBiotechnologyEsbrietFinancialImmunologicalsInterMuneMergers & AcquisitionsRespiratory and PulmonaryVidara Therapeutics

1 to 25 of 28 results

Back to top